North Central Neurology Associates, PC
Cullman, Alabama, United States
Neurologist in Cullman, Alabama
1809 Kress St, Cullman, AL 35058
About North Central Neurology Associates, PC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Genzyme, a Sanofi Company
3
Hoffmann-La Roche
3
EMD Serono Research & Development Institute, Inc.
2
Novartis
2
Opexa Therapeutics, Inc.
2
ACADIA Pharmaceuticals Inc.
1
Acorda Therapeutics
1
Avanir Pharmaceuticals
1
Biogen
1
Emerald Health Pharmaceuticals
1
Genentech, Inc.
1
Clinical Trials at North Central Neurology Associates, PC
During the past decade, North Central Neurology Associates, PC conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
2006-06-01
2011-08-01
Completed
1,083
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
2007-08-01
2011-04-01
Completed
581
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
2007-10-01
2011-09-01
Completed
840
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis
2007-11-01
2008-12-01
Terminated
116
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
2009-08-01
2016-02-01
Completed
1,314
Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
2010-10-01
2014-08-01
Terminated
24
Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
2011-02-01
2012-07-01
Completed
64
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "North Central Neurology Associates, PC" #1 sponsor was "Genzyme, a Sanofi Company" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Novartis" with 2 trials sponsored and "Opexa Therapeutics, Inc."
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "North Central Neurology Associates, PC"
#1 collaborator was "Bayer" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Mallinckrodt" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at North Central Neurology Associates, PC
According to Clinical.Site data, the most researched conditions in "North Central Neurology Associates, PC" are
"Multiple Sclerosis" (8 trials), "Multiple Sclerosis, Relapsing-Remitting" (7 trials), "Central Neuropathic Pain" (1 trials), "Clinically Isolated Syndrome" (1 trials) and "Parkinson Disease Psychosis" (1 trials). Many other conditions were trialed in "North Central Neurology Associates, PC" in a lesser frequency.
Clinical Trials Intervention Types at North Central Neurology Associates, PC
Most popular intervention types in "North Central Neurology Associates, PC" are "Drug" (13 trials), "Biological" (6 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Cladribine Tablets" (2 trials), "Interferon beta-1a" (2 trials), "Ocrelizumab" (2 trials) and "13-PCV Booster" (1 trials). Other intervention names were less common.
Clinical Trials Genders at North Central Neurology Associates, PC
The vast majority of trials in "North Central Neurology Associates, PC" are
20 trials for "All" genders.
Clinical Trials Status at North Central Neurology Associates, PC
Currently, there are NaN active trials in "North Central Neurology Associates, PC".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in North Central Neurology Associates, PC,
1 suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in North Central Neurology Associates, PC, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".